30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Strategic Initiatives

Kuros Biosciences Signs Distribution Agreement with Surgical Specialties for MagnetOs -

Kuros Biosciences entered into an agreement whereby Surgical Specialties will distribute MagnetOs synthetic bone graft in Australia and New Zealand. Kuros will supply the synthetic graft products, and Surgical Specialties will manage application and maintenance of regulatory and reimbursement approvals in the regions. First sales in Australia are expected in 2020. MagnetOs' submicron surface structure, applied during manufacturing, is designed to direct early wound healing toward a bone-forming pathway to support predictable healing and reliable fusion. The products have been granted an osteoinductive claim in Europe. (Kuros Biosciences, 7/9/19)